Blue Biofuels, INC 10-Q quarterly reports

Blue Biofuels, Inc. reported zero revenue for the quarter ended June 30, 2026, with a substantial accumulated deficit and significant concerns about its ability to continue as a going concern.

Blue Biofuels reports zero revenue for Q1 2026, with net losses widening due to increased R&D spending and a lack of government grant income compared to the prior year, while cash reserves dwindle.

Blue Biofuels, Inc. reported a significant net loss for the nine months ended September 30, 2025, while continuing to advance its patented cellulosic biofuel technology and strategic partnerships.

Blue Biofuels, Inc. reported a reduced net loss for Q2 2025 due to grant income, but faces significant liquidity challenges and a substantial going concern warning.

Blue Biofuels, Inc. reports its financial results for the quarter ended March 31, 2025, highlighting ongoing development of its CTS technology and plans for sustainable aviation fuel (SAF) production.

Blue Biofuels, Inc. reported its financial results for the quarter ended September 30, 2024, noting a significant gain from debt extinguishment and a new Department of Energy grant.

Blue Biofuels reported its second quarter 2024 financial results, highlighting ongoing efforts in technology development and strategic partnerships for sustainable aviation fuel production.

Blue Biofuels, Inc. has filed an amended quarterly report for Q1 2024 due to the suspension of its previous auditor, revealing continued losses and a working capital deficit.

Blue Biofuels reported its first quarter 2024 results, highlighting a joint venture for sustainable aviation fuel production and ongoing efforts to commercialize its cellulosic biofuel technology.